@misc{indiciae81d5faa1a757,
  title = {Cyclin A/B RxL Macrocyclic Inhibitors to Treat Cancers with High E2F Activity},
  author = {Singh, S. and Gleason, C. E. and Fang, M. and Laimon, Y. N. and Khivansara, V. and Xie, S. and Durmaz, Y. T. and Sarkar, A. and Ngo, K. and Savla, V. and Li, Y. and Abu-Remaileh, M. and Li, X. and Tuladhar, B. and Odeh, R. and Hamkins-Indik, F. and He, D. and Membreno, M. W. and Nosrati, M. and Gushwa, N. N. and Leung, S. S. F. and Fraga-Walton, B. and Hernandez, L. and Baldomero, M. P. and Lent, B. M. and Spellmeyer, D. and Luna, J. F. and Hoang, D. and Gritsenko, Y. and Chand, M. and DeMart, M. K. and Metobo, S. and Bhatt, C. and Shapiro, J. A. and Yang, K. and Dupper, N. J. and Bockus, A. T. and Doench, J. G. and Aggen, J. B. and Liu, L.-F. and Levin, B. and Wang, E. W. and Vendrell, I. and Fischer, R. and Kessler, B. M},
  year = {2024},
  doi = {10.1101/2024.08.01.605889},
  url = {https://www.biorxiv.org/content/10.1101/2024.08.01.605889v1},
  note = {Source identifier: 10.1101/2024.08.01.605889}
}